Search results (180)
« Back to NewsWellcome Career Development Award For Agne Antanaviciute
2 April 2025
Dr Agne Antanaviciute has won a Wellcome Career Development Award for her research investigating early-life immunity.
Technician Champion appointed in RDM
2 April 2025
Facility Manager Michalina Mazurczyk, based in the MRC Weatherall Institute of Molecular Medicine, has been appointed as Technician Champion for the second year.
New study reveals details of key immune mechanism
25 March 2025
An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
Ancient genomic linkage regulates red blood cell development
24 March 2025
A collaboration between the Drakesmith and Higgs Groups at the MRC Weatherall Institute of Molecular Medicine has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Wellcome Career Development Award For Sumana Sharma
14 March 2025
Dr Sumana Sharma has won a Wellcome Career Development Award for her research investigating receptors in T cells.
Adam Wilkinson wins 2025 ISEH Janet Rowley Award
13 March 2025
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
International Women's Day 2025
7 March 2025
For International Women's Day on 8th March 2025, women from the MRC WIMM reflect on why this day is so important, the barriers and biases women can face in their careers, and which women have inspired them.
Therapy Acceleration Lab granted UKAS accreditation
27 February 2025
The Therapy Acceleration Lab (TAL) at the MRC WIMM was recently accredited by the United Kingdom Accreditation Service (UKAS) to the ISO 17025:2017 Standard as a testing laboratory, No. 28562.
Funding awarded for new theatre-based community engagement project
23 January 2025
Alison Kay and Anne Goriely, together with Minna Jeffery (St. Anne’s College) and Lisa Hinton (Nuffield Dept. of Primary Care Health Sciences), have won an award from the University of Oxford’s PCER Fund for a project called “Making it personal”, which will use theatre to explore public perception of a new form of genetic testing.
Davis Group receives Wellcome Discovery Award
2 December 2024
Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.
RDM researchers at IF Oxford Science and Ideas Festival
19 November 2024
Researchers from RDM’s Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and the MRC Weatherall Institute of Molecular Medicine (WIMM) took centre stage at this year's IF Oxford Science and Ideas Festival with some exciting and interactive public engagement activities.
35 Years of the MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients
17 September 2024
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
Senior Fellowship awarded to Beth Psaila
28 August 2024
Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.
Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes
27 August 2024
Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
15 July 2024
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
New Fellow of the Academy of Medical Sciences
22 May 2024
Congratulations to Professor Adam Mead, who has been elected by the Academy of Medical Sciences to its fellowship.